• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Neurofilament light chain: An important step toward a disease biomarker in multiple sclerosis.

作者信息

Berger Thomas, Stüve Olaf

机构信息

From the Department of Neurology (T.B.), Medical University of Vienna, Austria; Department of Neurology and Neurotherapeutics (O.S.), University of Texas Southwestern Medical Center, Dallas; Neurology Section (O.S.), VA North Texas Health Care System, Medical Service, Dallas, TX; and Department of Neurology (O.S.), Klinikum rechts der Isar, Technische Universität München, Germany.

出版信息

Neurology. 2019 Mar 5;92(10):451-452. doi: 10.1212/WNL.0000000000007022. Epub 2019 Feb 8.

DOI:10.1212/WNL.0000000000007022
PMID:30737335
Abstract
摘要

相似文献

1
Neurofilament light chain: An important step toward a disease biomarker in multiple sclerosis.神经丝轻链：迈向多发性硬化症疾病生物标志物的重要一步。
Neurology. 2019 Mar 5;92(10):451-452. doi: 10.1212/WNL.0000000000007022. Epub 2019 Feb 8.
2
Challenges and Opportunities for the Promising Biomarker Blood Neurofilament Light Chain.有前景的生物标志物血液神经丝轻链面临的挑战与机遇
JAMA Neurol. 2023 Jun 1;80(6):542-543. doi: 10.1001/jamaneurol.2023.0394.
3
CSF neurofilament light: A universal risk biomarker in multiple sclerosis?脑脊液神经丝轻链：多发性硬化症的通用风险生物标志物？
Neurology. 2016 Sep 13;87(11):1068-9. doi: 10.1212/WNL.0000000000003107. Epub 2016 Aug 12.
4
Response to Hyun J.W. et al. "Longitudinal analysis of serum neurofilament light chain: A potential therapeutic monitoring biomarker for multiple sclerosis".对Hyun J.W.等人《血清神经丝轻链的纵向分析：多发性硬化症潜在的治疗监测生物标志物》的回应
Mult Scler. 2020 May;26(6):742-743. doi: 10.1177/1352458519854263. Epub 2019 May 30.
5
Neurofilament in CSF-A biomarker of disease activity and long-term prognosis in multiple sclerosis.脑脊液中的神经丝蛋白——多发性硬化症疾病活动和长期预后的生物标志物
Mult Scler. 2016 Aug;22(9):1112-3. doi: 10.1177/1352458516658560. Epub 2016 Jun 30.
6
Neurofilament light chain as a marker for cortical atrophy in multiple sclerosis without radiological signs of disease activity.神经丝轻链作为无疾病活动放射学征象的多发性硬化症皮质萎缩的标志物。
J Intern Med. 2021 Aug;290(2):473-476. doi: 10.1111/joim.13286. Epub 2021 Apr 19.
7
Relationship Between Serum Neurofilament Light and Multiple Sclerosis Disability Progression: Clear as Mud.血清神经丝轻链与多发性硬化症残疾进展之间的关系：仍不明确。
Neurology. 2021 Nov 9;97(19):887-888. doi: 10.1212/WNL.0000000000012755. Epub 2021 Sep 9.
8
Combined Neurofilament Light and Optical Coherence Tomography Better Predicts Multiple Sclerosis Disease Activity Than Either Measure Alone.与单独使用任何一种测量方法相比，联合神经丝轻链和光学相干断层扫描能更好地预测多发性硬化症的疾病活动。
Neurol Neuroimmunol Neuroinflamm. 2021 Aug 4;8(5). doi: 10.1212/NXI.0000000000001054. Print 2021 Sep.
9
Neurofilament in clinical practice: Is the multiple sclerosis community ready?临床实践中的神经丝：多发性硬化症群体准备好了吗？
Mult Scler. 2024 May;30(6):643-645. doi: 10.1177/13524585241246536. Epub 2024 Apr 11.
10
Plasma neurofilament light in progressive multiple sclerosis.进展性多发性硬化症中的血浆神经丝轻链
Acta Neurol Scand. 2020 Jan;141(1):14-15. doi: 10.1111/ane.13184.

引用本文的文献

1
Real-World Study of Serum Neurofilament Light Chain Levels in Ocrelizumab-Treated People with Relapsing Multiple Sclerosis.奥瑞珠单抗治疗复发型多发性硬化症患者血清神经丝轻链水平的真实世界研究
J Pers Med. 2024 Jun 27;14(7):692. doi: 10.3390/jpm14070692.
2
Serum NfL and EGFR/NfL ratio mRNAs as biomarkers for phenotype and disease severity of myelin oligodendrocyte glycoprotein IgG-associated disease.血清 NfL 和 EGFR/NfL 比值 mRNA 作为髓鞘少突胶质细胞糖蛋白 IgG 相关疾病表型和疾病严重程度的生物标志物。
Front Immunol. 2024 May 14;15:1388734. doi: 10.3389/fimmu.2024.1388734. eCollection 2024.
3
Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial.
APLIOS试验中复发型多发性硬化症患者的血清神经丝轻链轨迹及其与亚临床放射学疾病活动的关系。
Neurol Ther. 2023 Feb;12(1):303-317. doi: 10.1007/s40120-022-00427-8. Epub 2022 Dec 19.
4
Toward Precision Phenotyping of Multiple Sclerosis.迈向多发性硬化症的精准表型分析。
Neurol Neuroimmunol Neuroinflamm. 2022 Aug 30;9(6). doi: 10.1212/NXI.0000000000200025. Print 2022 Nov.
5
Should ocrelizumab be used in non-active primary progressive multiple sclerosis? Time for a re-assessment.奥瑞珠单抗是否应用于非活动性原发性进行性多发性硬化症？是时候重新评估了。
Ther Adv Neurol Disord. 2021 Feb 1;14:1756286421990500. doi: 10.1177/1756286421990500. eCollection 2021.
6
Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies.血清神经丝轻链和 GFAP 与水通道蛋白 4 或髓鞘少突胶质细胞糖蛋白抗体阳性的炎症性疾病的严重程度相关。
Front Immunol. 2021 Mar 16;12:647618. doi: 10.3389/fimmu.2021.647618. eCollection 2021.
7
A self-administered, artificial intelligence (AI) platform for cognitive assessment in multiple sclerosis (MS).用于多发性硬化症 (MS)认知评估的自我管理人工智能 (AI) 平台。
BMC Neurol. 2020 May 18;20(1):193. doi: 10.1186/s12883-020-01736-x.
8
Neurofilaments: neurobiological foundations for biomarker applications.神经丝：生物标志物应用的神经生物学基础。
Brain. 2020 Jul 1;143(7):1975-1998. doi: 10.1093/brain/awaa098.
9
Blood neurofilament light chain at the doorstep of clinical application.血液神经丝轻链迈向临床应用之际。
Neurol Neuroimmunol Neuroinflamm. 2019 Aug 8;6(5):e599. doi: 10.1212/NXI.0000000000000599. eCollection 2019 Sep.